AFANAT 30MG TABLET

Form: Tablets

Pack Size: 28 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹3236.93

NATCO PHARMA LTD (ONCOLOGY DIV): Afanat 30MG Tablet, 28 tablets, salt afatinib 30mg. NPPA has revised its MRP from Rs 3,956.25 to Rs 3,236.93 (18% lower) with effect from 09-11-2026; trade rate Rs 2,466.23. Group: EGFR tyrosine kinase inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: take on an empty stomach; early diarrhoea and rash management decides whether patients stay on it. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.